全文获取类型
收费全文 | 1757159篇 |
免费 | 140556篇 |
国内免费 | 6712篇 |
专业分类
耳鼻咽喉 | 22667篇 |
儿科学 | 57071篇 |
妇产科学 | 47494篇 |
基础医学 | 253051篇 |
口腔科学 | 48677篇 |
临床医学 | 157888篇 |
内科学 | 352371篇 |
皮肤病学 | 41962篇 |
神经病学 | 139775篇 |
特种医学 | 70416篇 |
外国民族医学 | 330篇 |
外科学 | 272438篇 |
综合类 | 38503篇 |
现状与发展 | 2篇 |
一般理论 | 533篇 |
预防医学 | 139869篇 |
眼科学 | 38379篇 |
药学 | 127337篇 |
5篇 | |
中国医学 | 3102篇 |
肿瘤学 | 92557篇 |
出版年
2018年 | 17270篇 |
2016年 | 15983篇 |
2015年 | 17819篇 |
2014年 | 24756篇 |
2013年 | 37481篇 |
2012年 | 46630篇 |
2011年 | 50597篇 |
2010年 | 31160篇 |
2009年 | 30175篇 |
2008年 | 47504篇 |
2007年 | 50755篇 |
2006年 | 51954篇 |
2005年 | 50093篇 |
2004年 | 48145篇 |
2003年 | 46740篇 |
2002年 | 44767篇 |
2001年 | 84476篇 |
2000年 | 87159篇 |
1999年 | 72524篇 |
1998年 | 21087篇 |
1997年 | 18733篇 |
1996年 | 19923篇 |
1995年 | 19811篇 |
1994年 | 18369篇 |
1993年 | 17392篇 |
1992年 | 59478篇 |
1991年 | 58808篇 |
1990年 | 57087篇 |
1989年 | 54696篇 |
1988年 | 50519篇 |
1987年 | 49779篇 |
1986年 | 46903篇 |
1985年 | 45225篇 |
1984年 | 34249篇 |
1983年 | 28957篇 |
1982年 | 17561篇 |
1981年 | 15911篇 |
1980年 | 14928篇 |
1979年 | 31408篇 |
1978年 | 22788篇 |
1977年 | 19240篇 |
1976年 | 17925篇 |
1975年 | 19202篇 |
1974年 | 22646篇 |
1973年 | 21534篇 |
1972年 | 20269篇 |
1971年 | 18882篇 |
1970年 | 17322篇 |
1969年 | 16333篇 |
1968年 | 15250篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
101.
Weiyu Ye Anna Olsson-Brown Robert A. Watson Vincent T. F. Cheung Robert D. Morgan Isar Nassiri Rosalin Cooper Chelsea A. Taylor Umair Akbani Oliver Brain Rubeta N. Matin Nicholas Coupe Mark R. Middleton Mark Coles Joseph J. Sacco Miranda J. Payne Benjamin P. Fairfax 《British journal of cancer》2021,124(10):1661
Background Immune checkpoint blockers (ICBs) activate CD8+ T cells, eliciting both anti-cancer activity and immune-related adverse events (irAEs). The relationship of irAEs with baseline parameters and clinical outcome is unclear.Methods Retrospective evaluation of irAEs on survival was performed across primary (N = 144) and secondary (N = 211) independent cohorts of patients with metastatic melanoma receiving single agent (pembrolizumab/nivolumab—sICB) or combination (nivolumab and ipilimumab—cICB) checkpoint blockade. RNA from pre-treatment and post-treatment CD8+ T cells was sequenced and differential gene expression according to irAE development assessed.Results 58.3% of patients developed early irAEs and this was associated with longer progression-free (PFS) and overall survival (OS) across both cohorts (log-rank test, OS: P < 0.0001). Median survival for patients without irAEs was 16.6 months (95% CI: 10.9–33.4) versus not-reached (P = 2.8 × 10−6). Pre-treatment monocyte and neutrophil counts, but not BMI, were additional predictors of clinical outcome. Differential expression of numerous gene pathway members was observed in CD8+ T cells according to irAE development, and patients not developing irAEs demonstrating upregulated CXCR1 pre- and post-treatment.Conclusions Early irAE development post-ICB is associated with favourable survival in MM. Development of irAEs is coupled to expression of numerous gene pathways, suggesting irAE development in-part reflects baseline immune activation.Subject terms: Immunotherapy, Melanoma 相似文献
102.
103.
104.
105.
106.
107.
108.
109.
Haya Mohammed BSc MChB M. Yousuf Salmasi MRCS Massimo Caputo PhD Gianni D. Angelini PhD Hunaid A. Vohra PhD 《Journal of cardiac surgery》2020,35(6):1209-1219
Background
Limited data exists demonstrating the efficacy of minimally invasive surgery (MIS) compared to median sternotomy (MS) for multiple valvular disease (MVD). This systematic review and meta-analysis aims to compare operative and peri-operative outcomes of MIS vs MS in MVD.Methods
PubMed, Ovid, and Embase were searched from inception until August 2019 for randomized and observational studies comparing MIS and MS in patients with MVD. Clinical outcomes of intra- and postoperative times, reoperation for bleeding and surgical site infection were evaluated.Results
Five observational studies comparing 340 MIS vs 414 MS patients were eligible for qualitative and quantitative review. The quality of evidence assessed using the Newcastle-Ottawa scale was good for all included studies. Meta-analysis demonstrated increased cardiopulmonary bypass time for MIS patients (weighted mean difference [WMD], 0.487; 95% confidence interval [CI], 0.365-0.608; P < .0001). Similarly, aortic cross-clamp time was longer in patients undergoing MIS (WMD, 0.632; 95% CI, 0.509-0.755; P < .0001). No differences were found in operative mortality, reoperation for bleeding, surgical site infection, or hospital stay.Conclusions
MIS for MVD have similar short-term outcomes compared to MS. This adds value to the use of minimally invasive methods for multivalvular surgery, despite conferring longer operative times. However, the paucity in literature and learning curve associated with MIS warrants further evidence, ideally randomized control trials, to support these findings.110.
F. Giovanardi F. Nudo Q. Lai M. Garofalo A. Consolo E. Choppin De Janvry G.A. Arroyo Murillo P. Ursi D. Stabile F. Melandro P.B. Berloco R. Pretagostini L. Poli 《Transplantation proceedings》2019,51(1):128-131